FTC Clears Forest Labs' $1.46B Furiex Buy
The Federal Trade Commission on Thursday closed its review of Forest Laboratories Inc.'s $1.46 billion bid for gastrointestinal drug specialist Furiex Pharmaceuticals Inc....To view the full article, register now.
Already a subscriber? Click here to view full article